These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11786762)

  • 61. Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach.
    Sciaudone G; Di Stazio C; Limongelli P; Guadagni I; Pellino G; Riegler G; Coscione P; Selvaggi F
    Can J Surg; 2010 Oct; 53(5):299-304. PubMed ID: 20858373
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Not Available].
    Ben Azouz S; Elleuch N; Dahmeni W; Hammami E; Braham A; Jaziri H; Ben Slema A; Ksiaa M; Jmaa A
    Tunis Med; 2024 Apr; 102(4):181-188. PubMed ID: 38746955
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predictors of long-term outcomes of radiologically defined perianal fistulizing Crohn's disease treated with antitumor necrosis factor-alpha agents based on Parks' classification.
    Azzam N; Alharbi O; Almadi M; Aljebreen A; AlAmeel T; Alabbas M; Bahammam S; Bashmail A; Alomar Y; Mosli M
    Eur J Gastroenterol Hepatol; 2020 Feb; 32(2):187-192. PubMed ID: 31851087
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease.
    Martínez-Borra J; López-Larrea C; González S; Fuentes D; Dieguez A; Deschamps EM; Pérez-Pariente JM; López-Vázquez A; de Francisco R; Rodrigo L
    Am J Gastroenterol; 2002 Sep; 97(9):2350-6. PubMed ID: 12358255
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diagnosis and treatment of fistulising Crohn's disease.
    Hvas CL; Dahlerup JF; Jacobsen BA; Ljungmann K; Qvist N; Staun M; Tøttrup A
    Dan Med Bull; 2011 Oct; 58(10):C4338. PubMed ID: 21975159
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Infliximab for the treatment of fistulas in patients with Crohn's disease.
    Present DH; Rutgeerts P; Targan S; Hanauer SB; Mayer L; van Hogezand RA; Podolsky DK; Sands BE; Braakman T; DeWoody KL; Schaible TF; van Deventer SJ
    N Engl J Med; 1999 May; 340(18):1398-405. PubMed ID: 10228190
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Infliximab therapy for Crohn's disease anoperineal lesions].
    Ouraghi A; Nieuviarts S; Mougenel JL; Allez M; Barthet M; Carbonnel F; Cosnes J; Gendre JP; Flourié B; Meurisse JJ; Quandalle P; Ernst O; Lemann M; Cortot A; Modigliani R; Colombel JF
    Gastroenterol Clin Biol; 2001 Nov; 25(11):949-56. PubMed ID: 11845044
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn's disease: results from a prospective study.
    Roumeguère P; Bouchard D; Pigot F; Castinel A; Juguet F; Gaye D; Capdepont M; Zerbib F; Laharie D
    Inflamm Bowel Dis; 2011 Jan; 17(1):69-76. PubMed ID: 20623697
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The long-term outcome of anti-TNF alpha therapy in perianal Crohn's disease.
    Rayen J; Currie T; Gearry RB; Frizelle F; Eglinton T
    Tech Coloproctol; 2017 Feb; 21(2):119-124. PubMed ID: 28066859
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians.
    Sandborn WJ; Hanauer SB
    Am J Gastroenterol; 2002 Dec; 97(12):2962-72. PubMed ID: 12492177
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prospective randomised controlled trial of adults with perianal fistulising Crohn's disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol.
    Gu B; De Gregorio M; Pipicella JL; Vande Casteele N; Andrews JM; Begun J; Connell W; D'Souza B; Gholamrezaei A; Hart A; Liew D; Radford-Smith G; Rimola J; Sutherland T; Toong C; Woods R; Wu Y; Xuan W; Williams AJ; Ng W; Ding NS; Connor S
    BMJ Open; 2021 Jul; 11(7):e043921. PubMed ID: 34210720
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessment and classification of fistula-in-ano in patients with Crohn's disease by hydrogen peroxide enhanced transanal ultrasound.
    Sloots CE; Felt-Bersma RJ; Poen AC; Cuesta MA; Meuwissen SG
    Int J Colorectal Dis; 2001 Sep; 16(5):292-7. PubMed ID: 11686526
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of perineal Crohn's disease on utilization of care in the absence of modifiable predictors of treatment failure.
    Dursun A; Hodin R; Bordeianou L
    Int J Colorectal Dis; 2014 Dec; 29(12):1535-9. PubMed ID: 25269618
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Palliative treatment of anal fistulas in Crohn's disease.
    Hermann J; Eder P; Banasiewicz T; Kołodziejczak B; Łykowska-Szuber L
    ANZ J Surg; 2016 Mar; 86(3):148-51. PubMed ID: 26861622
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Complete resolution of enterocolic fistulas with infliximab.
    Nunes J; Santos PM; Tavares L
    BioDrugs; 2010 Dec; 24 Suppl 1():28-30. PubMed ID: 21175233
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genital fistulas in female Crohn's disease patients.: clinical characteristics and response to therapy.
    de la Poza G; López-Sanroman A; Taxonera C; Marín-Jimenez I; Gisbert JP; Bermejo F; Opio V; Muriel A
    J Crohns Colitis; 2012 Apr; 6(3):276-80. PubMed ID: 22405162
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Predictors of response to infliximab in patients with fistulizing Crohn's disease.
    Luna-Chadid M; Pérez Calle JL; Mendoza JL; Vera MI; Bermejo AF; Sánchez F; López San Román A; Froilán C; González-Lara V; García-Paredes J; Fernández-Blanco I; Abreu L; Casis B; Solís Herruzo JA; Gisbert JP; Maté Jiménez J
    Rev Esp Enferm Dig; 2004 Jun; 96(6):379-81; 382-4. PubMed ID: 15230667
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Combined modality treatment for complex fistulating perianal Crohn's disease.
    Antakia R; Shorthouse AJ; Robinson K; Lobo AJ
    Colorectal Dis; 2013 Feb; 15(2):210-6. PubMed ID: 22672653
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fistula response to methotrexate in Crohn's disease: a case series.
    Mahadevan U; Marion JF; Present DH
    Aliment Pharmacol Ther; 2003 Nov; 18(10):1003-8. PubMed ID: 14616166
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Perianal fistulas in Crohn's disease--biologicals and surgery: is it worthwhile?].
    Bode M; Eder S; Schürmann G
    Z Gastroenterol; 2008 Dec; 46(12):1376-83. PubMed ID: 19053007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.